Advisory Board

The people who keep the science honest.

A multidisciplinary board of physicians, research scientists, and clinical leaders. Their expertise spans molecular diagnostics, cardiovascular medicine, biomedical engineering, behavioral health, and clinical research operations — and what each of them reviews is named below.

David L. Barnhart, Ed.D.

David L. Barnhart, Ed.D.

President and Founder, Behavioral Sciences of Alabama

Reviews

Reviews behavioral-health framing and how client-facing language stays defensible.

Board-certified clinical mental health counselor with more than four decades in human development and mental health services. Doctorate in Human Development Counseling from George Peabody College of Vanderbilt University. President and Founder of Behavioral Sciences of Alabama, an International OCD Foundation affiliate. Former Chairman of the Alabama Board of Examiners in Counseling.

Jeremy Blair

Jeremy Blair

Chief Executive Officer, WellStone

Reviews

Advises on operational scale and partner-program structure across multi-site care.

Chief Executive Officer of WellStone, a community mental health center in Huntsville, Alabama. More than 26 years leading non-profit behavioral healthcare. MBA from the University of North Alabama; master's in marriage and family therapy and a bachelor's in psychology from Harding University.

Lauren Diatte, M.D.

Lauren Diatte, M.D.

Board-Certified Pediatrician

Reviews

Reviews clinical readability and how results land with non-specialist providers.

Board-certified pediatrician across outpatient pediatrics and academic medicine. Pediatric residency training in California; practiced in California and Tennessee. Contributor to quality improvement initiatives and medical education, with research interests in adverse childhood experiences and long-term child health.

James C. Gilbert, M.D., F.A.C.S., F.A.A.P.

James C. Gilbert, M.D., F.A.C.S., F.A.A.P.

Founder and Senior Surgeon, Tennessee Valley Pediatric Surgery

Reviews

Reviews clinical claims to ensure they stay within what the evidence supports.

Board-certified surgeon with two decades of pediatric surgical care across North Alabama and Southern Tennessee. Medical degree from Harvard Medical School; general surgery training at Emory University; fellowships in liver transplantation from the Cleveland Clinic Foundation and pediatric surgery from Children's National Medical Center. Fellow of the American College of Surgeons and the American Academy of Pediatrics.

Mariame Selma Kane, Ph.D.

Mariame Selma Kane, Ph.D.

Assistant Professor and Biomedical Researcher

Reviews

Reviews the RNA expression methods and the analytical validity of the panel.

Biomedical research scientist and Assistant Professor with more than a decade across molecular biology, transcriptomics, genetics, and metabolic bioenergetics. Ph.D. in Biochemistry and Molecular Biology from the University of Angers, France; postdoctoral fellowships in mitochondrial and cardiovascular biology. Peer-reviewed work centers on RNA-based biomarker assessment and gene expression.

Rachel J. Keith, Ph.D., APRN, ANP-C

Rachel J. Keith, Ph.D., APRN, ANP-C

Associate Professor of Medicine, University of Louisville

Reviews

Reviews clinical trial design and how the panel is validated for partner use.

Associate Professor of Medicine at the University of Louisville School of Medicine, Director of the Human Subject Service Core within the Christina Lee Brown Envirome Institute, and a practicing Nurse Practitioner in Preventive Cardiology. More than 20 years in clinical research; author of more than 75 peer-reviewed publications.

William J. Tyler, Ph.D.

William J. Tyler, Ph.D.

Professor of Biomedical Engineering, University of Alabama at Birmingham

Reviews

Reviews the intervention-matching framework and technology direction.

Neurotechnology pioneer and Professor of Biomedical Engineering at the University of Alabama at Birmingham. Ph.D. in behavioral neuroscience and a postdoctoral fellowship at Harvard University. Co-founder of IST, LLC and co-founder and CTO of Diamond Therapeutics. Elected member of the National Academy of Inventors; more than 40 issued global patents.

iXpressGenes

CoreSignals™ Panel — a 22-signal peripheral blood RNA gene-expression panel for longevity, hormone-optimization, and recovery clinics.

Location

601 Genome Way NW
Huntsville, AL 35806
iXpressGenes.com

The CoreSignals™ Panel is a laboratory service provided by iXpressGenes, Inc., a CLIA-certified, CAP-accredited laboratory. Results measure RNA biomarker expression associated with inflammation and physiological stress responses and are intended for informational purposes only. CoreSignals™ does not diagnose, treat, or prevent any medical condition and does not constitute or act as a substitute for medical advice. Partner providers are solely responsible for how results are used and communicated to their clients.

© 2026 iXpressGenes, Inc. All rights reserved.